WhyWeVax (@whywevax) 's Twitter Profile
WhyWeVax

@whywevax

We provide you and your family with research-backed resources on #vaccines so you can make informed decisions that will keep you healthy.

ID: 1110611569766027266

linkhttp://whywevax.org calendar_today26-03-2019 18:36:47

601 Tweet

649 Followers

1,1K Following

WhyWeVax (@whywevax) 's Twitter Profile Photo

Great news! The mpox public health campaign has been a success, with cases remaining low. Ongoing efforts are ensuring continued protection and monitoring. Learn more: abcnews.go.com/Health/mpox-pu…

Great news! The mpox public health campaign has been a success, with cases remaining low. Ongoing efforts are ensuring continued protection and monitoring. Learn more:
abcnews.go.com/Health/mpox-pu…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Great news! The FDA has approved the first RSV vaccine for adults aged 60+. Arexvy by GSK showed over 82% effectiveness in preventing severe RSV infections. This is a major step in protecting older adults from serious respiratory illnesses. cbsnews.com/news/fda-appro…

Great news! The FDA has approved the first RSV vaccine for adults aged 60+. Arexvy by GSK showed over 82% effectiveness in preventing severe RSV infections. This is a major step in protecting older adults from serious respiratory illnesses.
cbsnews.com/news/fda-appro…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Big news from Moderna! Positive Phase III results for their COVID-19/Influenza mRNA vaccine, mRNA-1083, show strong immune responses. This combo vaccine could simplify protection against both viruses. Read more:clinicaltrialsarena.com/analyst-commen…

Big news from Moderna! Positive Phase III results for their COVID-19/Influenza mRNA vaccine, mRNA-1083, show strong immune responses. This combo vaccine could simplify protection against both viruses. Read more:clinicaltrialsarena.com/analyst-commen…
WhyWeVax (@whywevax) 's Twitter Profile Photo

New study highlights that the HPV vaccine significantly reduces cancer risk in men. This is a major step forward in preventing HPV-related cancers. Stay protected and informed! Read more: medicalnewstoday.com/articles/hpv-v…

New study highlights that the HPV vaccine significantly reduces cancer risk in men. This is a major step forward in preventing HPV-related cancers. Stay protected and informed! Read more: medicalnewstoday.com/articles/hpv-v…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Novavax has submitted an application to the FDA for its updated protein-based COVID-19 vaccine formula for 2024-2025. This new formula aims to enhance protection against emerging variants. Stay tuned for updates! Read more:ir.novavax.com/press-releases…

Novavax has submitted an application to the FDA for its updated protein-based COVID-19 vaccine formula for 2024-2025. This new formula aims to enhance protection against emerging variants. Stay tuned for updates! Read more:ir.novavax.com/press-releases…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Check out Mike Miller’s Kickstarter campaign for his upcoming book “Reversing Misinformation: How to Help Your Family, Friends, Community and World.” kickstarter.com/projects/rever…. Mike has been focusing on these issues during the pandemic and has terrific insights.

Check out Mike Miller’s Kickstarter campaign for his upcoming book “Reversing Misinformation: How to Help Your Family, Friends, Community and World.” kickstarter.com/projects/rever…. Mike has been focusing on these issues during the pandemic and has terrific insights.
WhyWeVax (@whywevax) 's Twitter Profile Photo

The latest CDC report on COVID-19 highlights significant updates on vaccination rates, breakthrough cases, and trends in hospitalizations and deaths. Stay informed about the evolving situation to protect yourself and others.cdc.gov/mmwr/volumes/7…

The latest CDC report on COVID-19 highlights significant updates on vaccination rates, breakthrough cases, and trends in hospitalizations and deaths. Stay informed about the evolving situation to protect yourself and others.cdc.gov/mmwr/volumes/7…
WhyWeVax (@whywevax) 's Twitter Profile Photo

French President Macron and African leaders are pushing for increased vaccination efforts in Africa following a recent polio outbreak. This initiative aims to strengthen healthcare and prevent future epidemics. Read more:abcnews.go.com/Health/wireSto…

French President Macron and African leaders are pushing for increased vaccination efforts in Africa following a recent polio outbreak. This initiative aims to strengthen healthcare and prevent future epidemics. Read more:abcnews.go.com/Health/wireSto…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Analysis shows global infectious disease outbreaks are surging due to falling vaccination rates, decreased population immunity, and climate change. Enhanced surveillance and timely interventions are crucial to control the spread. More details here: vaccinenation.org/infection/anal…

Analysis shows global infectious disease outbreaks are surging due to falling vaccination rates, decreased population immunity, and climate change. Enhanced surveillance and timely interventions are crucial to control the spread. More details here: vaccinenation.org/infection/anal…
WhyWeVax (@whywevax) 's Twitter Profile Photo

In a recent article, PharmaVoice discusses the hesitancy surrounding Moderna's new COVID-Flu combination vaccine. Concerns about effectiveness and public acceptance are being addressed by providing clear information and engaging with healthcare providers. pharmavoice.com/news/moderna-c…

In a recent article, <a href="/PharmaVoice/">PharmaVoice</a> discusses the hesitancy surrounding Moderna's new COVID-Flu combination vaccine. Concerns about effectiveness and public acceptance are being addressed by providing clear information and engaging with healthcare providers.
pharmavoice.com/news/moderna-c…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Pfizer and BioNTech receive positive CHMP opinion for their new COVID-19 vaccine targeting the XBB.1.5 subvariant, aiming to enhance protection against new strains. More info: morningstar.com/news/dow-jones…

Pfizer and BioNTech receive positive CHMP opinion for their new COVID-19 vaccine targeting the XBB.1.5 subvariant, aiming to enhance protection against new strains. More info: morningstar.com/news/dow-jones…
WhyWeVax (@whywevax) 's Twitter Profile Photo

In a new article, Health Day News reports that the CDC now recommends everyone over 6 months old get the updated COVID-19 vaccine to boost protection against new variants. Dr. Mandy Cohen emphasizes that vaccination is key to preventing severe outcomes. healthday.com/health-news/in…

In a new article, Health Day News reports that the CDC now recommends everyone over 6 months old get the updated COVID-19 vaccine to boost protection against new variants. Dr. Mandy Cohen emphasizes that vaccination is key to preventing severe outcomes.
healthday.com/health-news/in…
WhyWeVax (@whywevax) 's Twitter Profile Photo

New clinical trial begins for next-gen nasal COVID-19 vaccine. Researchers aim for enhanced, longer-lasting protection by targeting mucosal immunity. Early studies look promising! Read more: abcnews.go.com/Health/clinica… #vaccinessaveslives

New clinical trial begins for next-gen nasal COVID-19 vaccine. Researchers aim for enhanced, longer-lasting protection by targeting mucosal immunity. Early studies look promising!

Read more: abcnews.go.com/Health/clinica…

#vaccinessaveslives
WhyWeVax (@whywevax) 's Twitter Profile Photo

Latest news: "U.S. Government to Pay Moderna $176M to Develop mRNA Flu Vaccine" via U.S. News & World Report. This new initiative boosts investment in advanced vaccine tech for better pandemic preparedness. Read more: usnews.com/news/health-ne… #VaccinesSaveLives

Latest news: "U.S. Government to Pay Moderna $176M to Develop mRNA Flu Vaccine" via <a href="/usnews/">U.S. News & World Report</a>. This new initiative boosts investment in advanced vaccine tech for better pandemic preparedness.

Read more: usnews.com/news/health-ne…

#VaccinesSaveLives
WhyWeVax (@whywevax) 's Twitter Profile Photo

Latest from The New York Times: "Malaria Vaccine Delayed as Concerns Rise." Airfinity notes that post-pandemic changes may skew disease data. Read more: nytimes.com/2024/07/05/hea… #vaccinessaveslives

Latest from <a href="/nytimes/">The New York Times</a>: "Malaria Vaccine Delayed as Concerns Rise." Airfinity notes that post-pandemic changes may skew disease data. Read more: nytimes.com/2024/07/05/hea… 
#vaccinessaveslives
WhyWeVax (@whywevax) 's Twitter Profile Photo

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: medscape.com/viewarticle/ne… #vaccinessaveslives

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: medscape.com/viewarticle/ne…
 #vaccinessaveslives
WhyWeVax (@whywevax) 's Twitter Profile Photo

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: medscape.com/viewarticle/ne… #vaccinessaveslives

Latest article: "New Mid-Year Vaccine Recommendations Announced," @medscape reports on ACIP's updated guidelines for 2024, reflecting recent outbreaks and post-pandemic changes. Read more: medscape.com/viewarticle/ne…
 #vaccinessaveslives
WhyWeVax (@whywevax) 's Twitter Profile Photo

In the latest article: "First Clinical Trial for Nasal COVID-19 Vaccine," @medeconomics highlights new vaccine developments and health updates. CDC notes changes in testing may skew disease data. Read more: medicaleconomics.com/view/first-cli… #vaccinessaveslives

In the latest article: "First Clinical Trial for Nasal COVID-19 Vaccine," @medeconomics highlights new vaccine developments and health updates. CDC notes changes in testing may skew disease data. Read more: medicaleconomics.com/view/first-cli… #vaccinessaveslives
WhyWeVax (@whywevax) 's Twitter Profile Photo

Latest article: "Kids' Health at Risk as Vaccination Rates Drop Worldwide," Axios highlights a troubling decline in global vaccination rates. Experts warn of potential disease resurgence. Read more: axios.com/2024/07/16/kid…

Latest article: "Kids' Health at Risk as Vaccination Rates Drop Worldwide," <a href="/axios/">Axios</a> highlights a troubling decline in global vaccination rates. Experts warn of potential disease resurgence. Read more: axios.com/2024/07/16/kid…
WhyWeVax (@whywevax) 's Twitter Profile Photo

Concerned about toxic misinformation? Check out Dr. Mike Miller’s new book, “Reversing Misinformation.” Details on the Kickstarter page, including videos and interviews: kickstarter.com/projects/rever… . Learn more about Dr. Miller's expertise here: linkedin.com/in/michael-mil…

Concerned about toxic misinformation? Check out Dr. Mike Miller’s new book, “Reversing Misinformation.” Details on the Kickstarter page, including videos and interviews: kickstarter.com/projects/rever… . Learn more about Dr. Miller's expertise here: linkedin.com/in/michael-mil…